Helius Therapeutics, the leading New Zealand-based medicinal cannabis company, is excited to announce the launch of two innovative new products aimed at improving the quality of life for patients seeking alternative treatments
Prescriptions for medicinal cannabis increased 14 times in four years, and there has been a big shift from CBD oral liquids to much more potent THC-dominated flower/bud products, a recent study of New Zealand’s medicinal cannabis scheme has found.
With prescriptions for medicinal cannabis on the rise, a group of 40 Auckland pharmacists last week toured New Zealand’s largest medicinal cannabis production facility to learn more about the product
Covered up in hair net and gown, Zach Thompson ventures behind the fence and into the Helius Therapeutics medicinal cannabis growing and manufacturing facility
THE MEDICINES Classification Committee decision not to ease restrictions on low-dose cannabidiol, means businesses have no incentive to bring these products to market, a Hamilton-based pharmacist says.